Literature DB >> 9449473

The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies.

C Ballard1, I McKeith, D Burn, R Harrison, J O'Brien, K Lowery, M Campbell, R Perry, P Ince.   

Abstract

The study aimed to evaluate the merits of the Unified Parkinson's Disease Rating Scale (UPDRS) in the assessment of parkinsonism in patients suffering from Dementia with Lewy Bodies (DLB). Parkinsonian symptoms were assessed in 73 dementia patients using the UPDRS and staged using the Hoehn & Yahr system. A staging of 1 or greater was taken to indicate significant parkinsonism. DLB (n=42) was diagnosed using the McKeith et al. criteria, Alzheimer's disease (n=30) was diagnosed using the NINCDS ADRDA criteria. The inability of some patients to comply with some of the more complicated tasks meant that the full UPDRS assessment could only be completed in 35 (83%) of the DLB patients, 23 (66%) of whom had significant parkinsonism. Patients with parkinsonism were significantly younger than those without. A Principal Components Analysis derived a sub-scale including the items tremor at rest, action tremor, bradykinesia, facial expression and rigidity. These items had a specificity of 100% and a sensitivity of 85% for significant parkinsonism using a cut-off of 7/8. The brief scale had several advantages over the complete UPDRS. Unlike the full scale it was independent of the severity of cognitive impairment and the 5 key items could be assessed in 41 (98%) of the DLB patients. Autopsies have been completed on 31 patients, with a specificity of greater than 90% for the operationalized clinical diagnosis of DLB. It is suggested that a 5 item subscale of the UPDRS provides a reliable and generally applicable instrument for the assessment of parkinsonism in DLB patients.

Entities:  

Mesh:

Year:  1997        PMID: 9449473     DOI: 10.1111/j.1600-0404.1997.tb00299.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  15 in total

Review 1.  Synucleinopathies: common features and hippocampal manifestations.

Authors:  Weiwei Yang; Shun Yu
Journal:  Cell Mol Life Sci       Date:  2016-11-08       Impact factor: 9.261

2.  Extrapyramidal signs by dementia severity in Alzheimer disease and dementia with Lewy bodies.

Authors:  Berneet Kaur; Danielle J Harvey; Charles S Decarli; Lin Zhang; Marwan N Sabbagh; John M Olichney
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

3.  The role of levodopa in the management of dementia with Lewy bodies.

Authors:  S Molloy; I G McKeith; J T O'Brien; D J Burn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

4.  Efficacy and safety of memantine in Lewy body dementia.

Authors:  O S Levin; L A Batukaeva; I G Smolentseva; N A Amosova
Journal:  Neurosci Behav Physiol       Date:  2009-07

5.  Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions.

Authors:  R A Kenny; F E Shaw; J T O'Brien; P H Scheltens; R Kalaria; C Ballard
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

6.  Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults.

Authors:  Caterina Rosano; Jennifer Brach; Stephanie Studenski; W T Longstreth; Anne B Newman
Journal:  Neuroepidemiology       Date:  2007-11-27       Impact factor: 3.282

7.  Cognitive phenotype of psychotic symptoms in Alzheimer's disease: evidence for impaired visuoperceptual function in the misidentification subtype.

Authors:  Suzanne J Reeves; Chloe Clark-Papasavas; Rebecca L Gould; Dominic Ffytche; Robert J Howard
Journal:  Int J Geriatr Psychiatry       Date:  2015-03-24       Impact factor: 3.485

8.  A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).

Authors:  Clive Ballard; Marisa Margallo Lana; Megan Theodoulou; Simon Douglas; Rupert McShane; Robin Jacoby; Katja Kossakowski; Ly-Mee Yu; Edmund Juszczak
Journal:  PLoS Med       Date:  2008-04-01       Impact factor: 11.069

9.  Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies.

Authors:  Marco Onofrj; Sara Varanese; Laura Bonanni; John-Paul Taylor; Angelo Antonini; Enza Maria Valente; Simona Petrucci; Fabrizio Stocchi; Astrid Thomas; Bernardo Perfetti
Journal:  J Neurol       Date:  2013-02-12       Impact factor: 4.849

10.  Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study.

Authors:  Alan J Thomas; John Paul Taylor; Ian McKeith; Claire Bamford; David Burn; Louise Allan; John O'Brien
Journal:  Int J Geriatr Psychiatry       Date:  2016-12-08       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.